BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7943034)

  • 1. Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase.
    Chong SS; Eichler EE; Nelson DL; Hughes MR
    Am J Med Genet; 1994 Jul; 51(4):522-6. PubMed ID: 7943034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple fragile X PCR assay with 7-deazaguanine-substituted DNA visualized by ethidium bromide.
    Cao J; Tarleton J; Barberio D; Davidow LS
    Mol Cell Probes; 1994 Apr; 8(2):177-80. PubMed ID: 7935515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved sizing of fragile X CCG repeats by nested polymerase chain reaction.
    Levinson G; Maddalena A; Palmer FT; Harton GL; Bick DP; Howard-Peebles PN; Black SH; Schulman JD
    Am J Med Genet; 1994 Jul; 51(4):527-34. PubMed ID: 7943035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG.
    Sermon K; Seneca S; Vanderfaeillie A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
    Prenat Diagn; 1999 Dec; 19(13):1223-30. PubMed ID: 10660959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene.
    van den Ouweland AM; de Vries BB; Bakker PL; Deelen WH; de Graaff E; van Hemel JO; Oostra BA; Niermeijer MF; Halley DJ
    Am J Med Genet; 1994 Jul; 51(4):482-5. PubMed ID: 7943024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive screening of fragile X syndrome A using urine and hair roots.
    Suwa K; Momoi MY
    Brain Dev; 2004 Sep; 26(6):380-3. PubMed ID: 15275700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers.
    Apessos A; Abou-Sleiman PM; Harper JC; Delhanty JD
    Prenat Diagn; 2001 Jun; 21(6):504-11. PubMed ID: 11438958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the gene FMR2, associated with FRAXE mental retardation.
    Gecz J; Gedeon AK; Sutherland GR; Mulley JC
    Nat Genet; 1996 May; 13(1):105-8. PubMed ID: 8673085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for reliable prenatal detection of normal male carriers of the fragile X syndrome.
    Halley D; Van Den Ouweland A; Deelen W; Verma I; Oostra B
    Am J Med Genet; 1994 Jul; 51(4):471-3. PubMed ID: 7943022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives and molecular diagnosis of the fragile X syndrome.
    Brown WT
    Clin Lab Med; 1995 Dec; 15(4):859-75. PubMed ID: 8838227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of unstable DNA sequence in FMR1 gene in Polish families with fragile X syndrome.
    Milewski M; Zygulska M; Bal J; Deelen WH; Obersztyn E; Bocian E; Halley DJ; Horst J; Mazurczak T
    Acta Biochim Pol; 1996; 43(2):383-8. PubMed ID: 8862184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel duplication in the FMR1 gene: implications for molecular analysis in fragile X syndrome and repeat instability.
    Mononen T; von Koskull H; Airaksinen RL; Juvonen V
    Clin Genet; 2007 Dec; 72(6):528-31. PubMed ID: 17922850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular biologic screening test (PCR) for fragile X syndrome].
    Kovács E; Morava E; Nádasi E; Czakó M; Melegh B; Kosztolányi G
    Orv Hetil; 1998 Dec; 139(52):3121-3. PubMed ID: 9914733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
    Santos CB; Costa Lima MA; Pimentel MM
    Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation in the FMR-1 gene associated with fragile X mental retardation.
    De Boulle K; Verkerk AJ; Reyniers E; Vits L; Hendrickx J; Van Roy B; Van den Bos F; de Graaff E; Oostra BA; Willems PJ
    Nat Genet; 1993 Jan; 3(1):31-5. PubMed ID: 8490650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.